Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ollivier Legrand

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Haematologica|February 3, 2004
P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groupsOllivier Legrand, Simona Zompi, Jean-Yves Perrot, et al.
Molecular Cancer Therapeutics|March 21, 2006
Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cellsRuoping Tang, Anne-Marie Faussat, Patricia Majdak, et al.
Journal of Digestive Diseases|August 27, 2024
Dramatic ruxolitinib efficacy in chronic enteropathy associated with SLCO2A1 gene (CEAS)Laure Ricard, Fabienne Charbit-Henrion, Alice Courties, et al.
Blood|August 1, 2009
High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemiaRuoping Tang, Pierre Hirsch, Fanny Fava, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 25, 2019
Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An UpdateGiorgia Battipaglia, Radwan Massoud, Syed Osman Ahmed, et al.
Leukemia & Lymphoma|April 15, 2014
Acute myeloid leukemia in patients older than 75: prognostic impact of FLT3-ITD and NPM1 mutationsPierre Hirsch, Ghazi Qassa, Christophe Marzac, et al.
Haematologica|November 8, 2011
Prognostic impact of high ABC transporter activity in 111 adult acute myeloid leukemia patients with normal cytogenetics when compared to FLT3, NPM1, CEBPA and BAALCPierre Hirsch, Ruoping Tang, Christophe Marzac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Flt3 internal tandem duplication and P-glycoprotein functionality in 171 patients with acute myeloid leukemiaChristophe Marzac, I Teyssandier, Ors'Anton Calendini, et al.
Leukemia Research|May 4, 2010
Outcome of 40 adults aged from 18 to 55 years with acute lymphoblastic leukemia treated with double-delayed intensification pediatric protocolStéphanie Haïat, Zora Marjanovic, Simona Lapusan, et al.
Cytometry. Part B, Clinical Cytometry|March 29, 2006
JC-1, a sensitive probe for a simultaneous detection of P-glycoprotein activity and apoptosis in leukemic cellsDriss Chaoui, Anne-Marie Faussat, Patricia Majdak, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Haematologica|February 3, 2004
P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groupsOllivier Legrand, Simona Zompi, Jean-Yves Perrot, et al.
Molecular Cancer Therapeutics|March 21, 2006
Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cellsRuoping Tang, Anne-Marie Faussat, Patricia Majdak, et al.
Journal of Digestive Diseases|August 27, 2024
Dramatic ruxolitinib efficacy in chronic enteropathy associated with SLCO2A1 gene (CEAS)Laure Ricard, Fabienne Charbit-Henrion, Alice Courties, et al.
Blood|August 1, 2009
High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemiaRuoping Tang, Pierre Hirsch, Fanny Fava, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 25, 2019
Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An UpdateGiorgia Battipaglia, Radwan Massoud, Syed Osman Ahmed, et al.
Leukemia & Lymphoma|April 15, 2014
Acute myeloid leukemia in patients older than 75: prognostic impact of FLT3-ITD and NPM1 mutationsPierre Hirsch, Ghazi Qassa, Christophe Marzac, et al.
Haematologica|November 8, 2011
Prognostic impact of high ABC transporter activity in 111 adult acute myeloid leukemia patients with normal cytogenetics when compared to FLT3, NPM1, CEBPA and BAALCPierre Hirsch, Ruoping Tang, Christophe Marzac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Flt3 internal tandem duplication and P-glycoprotein functionality in 171 patients with acute myeloid leukemiaChristophe Marzac, I Teyssandier, Ors'Anton Calendini, et al.
Leukemia Research|May 4, 2010
Outcome of 40 adults aged from 18 to 55 years with acute lymphoblastic leukemia treated with double-delayed intensification pediatric protocolStéphanie Haïat, Zora Marjanovic, Simona Lapusan, et al.
Cytometry. Part B, Clinical Cytometry|March 29, 2006
JC-1, a sensitive probe for a simultaneous detection of P-glycoprotein activity and apoptosis in leukemic cellsDriss Chaoui, Anne-Marie Faussat, Patricia Majdak, et al.
Pageof 8